ahlam1399
03-16-2016, 09:50 PM
U.S. jury rules for Amgen over cholesterol drug patents
March 16 (Reuters) - A federal jury has ruled in favor of Amgen Inc and against Sa**fi SA and Regeneron Pharmaceuticals Inc in a trial over the validity of patents for antibodies related to a cholesterol drug, Sa**fi and Regeneron said in a joint statement on Wednesday.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e4f0326/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=UErpnMKNahk:XafH_2Mwv_g:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=UErpnMKNahk:XafH_2Mwv_g:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=UErpnMKNahk:XafH_2Mwv_g:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=UErpnMKNahk:XafH_2Mwv_g:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=UErpnMKNahk:XafH_2Mwv_g:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/UErpnMKNahk
March 16 (Reuters) - A federal jury has ruled in favor of Amgen Inc and against Sa**fi SA and Regeneron Pharmaceuticals Inc in a trial over the validity of patents for antibodies related to a cholesterol drug, Sa**fi and Regeneron said in a joint statement on Wednesday.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e4f0326/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=UErpnMKNahk:XafH_2Mwv_g:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=UErpnMKNahk:XafH_2Mwv_g:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=UErpnMKNahk:XafH_2Mwv_g:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=UErpnMKNahk:XafH_2Mwv_g:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=UErpnMKNahk:XafH_2Mwv_g:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/UErpnMKNahk